ifosfamide has been researched along with Experimental Mammary Neoplasms in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " An extension of the comparative study to the in vivo model of murine C3H mammary adenocarcinoma yielded synergistic effects, if the animals were treated with 10 MeV electrons and one of the drugs: cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide." | 7.68 | Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph ( Ulmer, W, 1991) |
| " An extension of the comparative study to the in vivo model of murine C3H mammary adenocarcinoma yielded synergistic effects, if the animals were treated with 10 MeV electrons and one of the drugs: cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide." | 3.68 | Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph ( Ulmer, W, 1991) |
| "Three murine tumor lines, B16 melanoma, C38 colon cancer and M2661 breast cancer, were used to evaluate the therapeutic efficacy of the drug combination ACNU and ifosfamide." | 3.68 | Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer. ( Nooter, K; Silbermann, MH; Stoter, G; vd Vecht, B; Verweij, J, 1990) |
| " Oral bioavailability in rats was 48-73% of parenteral administration, and antitumor activity in mice was equivalent by both routes." | 1.38 | Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. ( Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP, 2012) |
| "Ifosfamide (IFF) is a nitrogen mustard with significant activity against a number of tumors." | 1.29 | Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model. ( Batist, G; Granvil, CP; Wainer, IW; Wang, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, B | 1 |
| Komarnitsky, P | 1 |
| Miller, GT | 1 |
| Amedio, J | 1 |
| Wallner, BP | 1 |
| Struck, RF | 1 |
| Dykes, DJ | 1 |
| Corbett, TH | 1 |
| Suling, WJ | 1 |
| Trader, MW | 1 |
| Wainer, IW | 1 |
| Granvil, CP | 1 |
| Wang, T | 1 |
| Batist, G | 1 |
| Kammertoens, T | 1 |
| Gelbmann, W | 1 |
| Karle, P | 1 |
| Alton, K | 1 |
| Saller, R | 1 |
| Salmons, B | 1 |
| Günzburg, WH | 1 |
| Uckert, W | 1 |
| Ulmer, W | 1 |
| Silbermann, MH | 1 |
| vd Vecht, B | 1 |
| Stoter, G | 1 |
| Nooter, K | 1 |
| Verweij, J | 1 |
| Kuśnierczyk, H | 1 |
| Radzikowski, C | 1 |
| Paprocka, M | 1 |
| Budzyński, W | 1 |
| Rak, J | 1 |
| Kinas, R | 1 |
| Misiura, K | 1 |
| Stec, W | 1 |
8 other studies available for ifosfamide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 2012 |
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide; | 1983 |
Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model.
Topics: Animals; Body Weight; Bone Marrow; Drug Screening Assays, Antitumor; Female; Ifosfamide; Lethal Dose | 1994 |
Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.
Topics: Animals; Cats; Cell Line; Cell Transplantation; Cytochrome P-450 CYP2B1; Cytosine Deaminase; Female; | 2000 |
Report on carcinogenesis bioassay of isophosphamide.
Topics: Animals; Carcinogens; Cyclophosphamide; Cystitis; Dogs; Female; Hair; Ifosfamide; Lymphoma; Male; Ma | 1978 |
Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biophysical Phenomena; Biop | 1991 |
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Synergism; Ifosfami | 1990 |
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide; | 1986 |